Literature DB >> 27143495

Impact of physical activity on nonalcoholic steatohepatitis in people with nonalcoholic simple fatty liver: A prospective cohort study.

Kenji Tsunoda1, Yuko Kai2, Naruki Kitano3, Ken Uchida4, Tsutomu Kuchiki5, Toshiya Nagamatsu6.   

Abstract

Preventing nonalcoholic simple fatty liver (NASFL) from progressing to nonalcoholic steatohepatitis (NASH) is a key to avoiding cirrhosis. Physical activity (PA) may help manage fatty liver; however, there is a lack of prospective studies showing an association between PA and NASH. Our current prospective study investigated whether PA prevents NASFL from progressing to NASH. Study data were obtained from the health check-up program of Meiji Yasuda Shinjuku Medical Center in Tokyo, Japan. From a baseline survey between 2005 and 2007, 1149 people with NASFL met eligibility criteria including low alcohol consumption. We followed participants until 2014 assessing liver status via ultrasound and liver enzyme levels, including alanine aminotransferase (ALT) and aspartate aminotransferase (AST). We classified participants with fatty liver and higher levels of either ALT or AST as having NASH. Through a self-reported questionnaire, we classified PA into three intensities: moderate low-intensity PA (MLPA, 3-5 METs), moderate high-intensity PA (MHPA, 5-7 METs), and vigorous-intensity PA (VPA, ≥7 METs). During a mean follow-up of 4.2years (4804person-years), 318 of the 1149 participants (27.7%) progressed from NASFL to NASH. A multivariate-adjusted Cox model showed a significant preventive effect of VPA on progression to NASH (HR=0.55, 95% CI=0.32-0.94) and no significant associations between MLPA (HR=1.01, 95% CI=0.79-1.30) or MHPA (HR=0.97, 95% CI=0.66-1.42) and progression to NASH. Only VPA prevented NASFL from progressing to NASH; MLPA and MHPA had no preventive effect on NASH. Higher intensity PA may be needed to manage NASH.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exercise; Hepatic steatosis; NAFLD; NASH; Obesity

Mesh:

Substances:

Year:  2016        PMID: 27143495     DOI: 10.1016/j.ypmed.2016.04.020

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

Review 1.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

Review 2.  Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.

Authors:  Min-Sun Kwak; Donghee Kim
Journal:  Korean J Intern Med       Date:  2017-12-06       Impact factor: 2.884

3.  Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Krzysztof Drygalski; Katarzyna Siewko; Andrzej Chomentowski; Cezary Odrzygóźdź; Anna Zalewska; Adam Krętowski; Mateusz Maciejczyk
Journal:  Oxid Med Cell Longev       Date:  2021-01-14       Impact factor: 6.543

4.  Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD-Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2α/CHOP Signal Pathways.

Authors:  Ling Ruan; Fanghui Li; Shoubang Li; Mingjun Zhang; Feng Wang; Xianli Lv; Qin Liu
Journal:  Oxid Med Cell Longev       Date:  2021-03-15       Impact factor: 6.543

5.  Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD.

Authors:  Theresia M Schnurr; Sophia Figueroa Katz; Johanne M Justesen; Jack W O'Sullivan; Peter Saliba-Gustafsson; Themistocles L Assimes; Ivan Carcamo-Orive; Aijaz Ahmed; Euan A Ashley; Torben Hansen; Joshua W Knowles
Journal:  Hepatol Commun       Date:  2022-03-15

6.  HIIT and MICT attenuate high-fat diet-induced hepatic lipid accumulation and ER stress via the PERK-ATF4-CHOP signaling pathway.

Authors:  Zhang Yuan; Liu Xiao-Wei; Wei Juan; Liu Xiu-Juan; Zhang Nian-Yun; Sheng Lei
Journal:  J Physiol Biochem       Date:  2022-03-22       Impact factor: 5.080

7.  Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.

Authors:  Anja Baumann; Cheng Jun Jin; Annette Brandt; Cathrin Sellmann; Anika Nier; Markus Burkard; Sascha Venturelli; Ina Bergheim
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.